本文章的引用
本文章的通讯作者
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
- 本文章浏览次数 (2049)
All Articles published online
|
2016-01-28 (publication date) through 2024-06-06
本文章的被引频次
本文章的期刊信息
出版物名称
世界华人消化杂志
ISSN
1009-3079
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | 邓文珺, 马颖才, 马丽莉. 美沙拉嗪联合丹参注射液治疗溃疡性结肠炎的疗效及对患者炎性因子与凝血指标的影响. 世界华人消化杂志 2016; 24(3): 462-466 [DOI: 10.11569/wcjd.v24.i3.462] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v24/i3/462.htm |
| 编号 | Citing Articles |
| 1 |
Wei Zhang, Peiyu Xiong, Junyu Liu, Hengchang Hu, Li Song, Xinglong Liu, Bo Jia. A systematic review and meta-analysis of Danshen combined with mesalazine for the treatment of ulcerative colitis. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1334474
|
| 2 |
Mingkuan Zhang, Yuan Su, Qian Gao, Miaomiao Zhou, Ying Xing, Zhibin Chen, Xiaoyu Liu, Zifa Li, Xiwen Geng, Guimao Cao, Hao Zhang, Sheng Wei. Efficacy and safety of Chinese patent medicine combined with 5-aminosalicylic acid for patients with ulcerative colitis: A network meta-analysis of randomized controlled trials. Heliyon 2024; 10(10): e31182 doi: 10.1016/j.heliyon.2024.e31182
|
| 3 |
Yu-Xin Sun, Guo-Yan Yang, Diana Karamacoska, Xiao Wang, Yuan-Xi Li, Wen-Bin Hou, You-You Zheng, Jian-Ping Liu, Zhao-Lan Liu, Ivan Luzardo-Ocampo. Chinese Patent Medicine as Adjuvant for Mild-to-Moderate Active Ulcerative Colitis: A Network Meta-Analysis of Randomized Controlled Trials. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/1075886
|
| 4 |
Siyuan Zhang, Hua Luo, Shiyi Sun, Yating Zhang, Jiaqi Ma, Yuting Lin, Lin Yang, Dechao Tan, Chaomei Fu, Zhangfeng Zhong, Yitao Wang. Salvia miltiorrhiza Bge. (Danshen) for Inflammatory Bowel Disease: Clinical Evidence and Network Pharmacology-Based Strategy for Developing Supplementary Medical Application. Frontiers in Pharmacology 2022; 12 doi: 10.3389/fphar.2021.741871
|